Global clinical trial provider joins forces with digital health company to develop new data management system
ST. LOUIS, MO - Biomedical Systems - a 40-year-old, family-owned, leading clinical trial provider to pharmaceutical, medical device, biotech, and contract research organizations (CROs) – announced a new partnership with digital health company Foundry Health of Chicago. The two companies will collaborate on the development of a proprietary cloud-based data management system that will allow sponsors immediate access to clinical trial data in real time.
"We've been a leader in the clinical trials industry for more than 40 years, and we continue to invest in technologies that improve data management capabilities for our clients," said Tim Barrett, CEO, Biomedical Systems. "Our partnership with Foundry Health will result in a best-in-class data management solution, and we are dedicating significant resources to accelerate its availability."
Since 2013, Foundry Health has specialized in the development of patient-centric software tools and systems for use in clinical trials and medical settings. The company is best known for the creation of ClinSpark, the world's first CDISC ODM certified phase l eSource system.
"The partnership with Biomedical Systems will provide clients a continuum of data management for all phases of study," said Brock Heinz, CEO, Foundry Health. "Biomedical Systems will focus on applications in phases two through four, while Foundry Health will continue to service clients, concentrating on phase one. We believe the product we are developing together will ultimately transform the way data is managed and accessed within clinical trials."
The new data management system will be phased in over time and made available to all Biomedical Systems clients.
"Foundry Health is a trusted leader in the digital health space," said Jim Ott, chief technology officer, Biomedical Systems. "We are proud to partner with Foundry Health's experts as we strive to provide our clients with the tools necessary to capture, analyze and effectively manage data for clinical trials."
About Biomedical Systems
Biomedical Systems is a premier global provider of centralized diagnostic services. Founded in 1975, Biomedical Systems has grown to be a leading clinical trial provider to pharmaceutical, medical device, biotech, and CROs. Its comprehensive clinical trial solutions include cardiac safety, pulmonary function, imaging, eCOA, and scientific affairs.
Biomedical Systems' corporate headquarters is located in St. Louis, Missouri. European headquarters is located in Brussels, Belgium with supporting offices in Japan, China and India, which are able to resupply equipment and materials to challenging areas around the world in a timely, cost-effective manner. Its global staff speaks 21 languages, facilitating communication with international sponsors and sites delivering better quality data. With five strategically located offices spanning the globe, Biomedical Systems has managed thousands of clinical trials in over 95 countries and can offer services and support 24 hours a day. For more information, visit http://www.biomedsys.com/.
About Foundry Health
Foundry Health is a digital health company that seeks to empower health professionals by building software tools that put the patient back at the center of each encounter. As the creators of ClinSpark, the world's first CDISC ODM certified phase l eSource system, Foundry Health is revolutionizing the way early phase trials are conducted. For more information, visit http://www.foundryhealth.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.